Chargement en cours...
Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy
The pathogenesis of glaucoma is strongly associated with the occurrence of autoimmune-mediated loss of retinal ganglion cells (RGCs) and additionally, recent evidence shows that specific antibody-derived signature peptides are significantly differentially expressed in sera of primary-open angle glau...
Enregistré dans:
| Publié dans: | J Clin Med |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6723090/ https://ncbi.nlm.nih.gov/pubmed/31443184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8081222 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|